Delivery Order SPE2DB20D2002-SPE2DB23FL23T

Award Date 3/1/23
Potential Completion Date 3/2/23
Potential Value $3.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $36,674.00, is for the delivery of Havrix 1,440 unit/mL syringes. The contract has a firm fixed price and is set to complete by November 6, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,925.10 firm fixed-price contract is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products, with a completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Havrix 1,440 unit/mL syringes. The contract, valued at $2,109.27, is a firm fixed-price delivery order with a completion date of May 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.55 firm fixed-price contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medication, with a completion date of June 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medical products. The award, valued at $5,953.53, has a firm fixed-price contract type and an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to various government agencies and healthcare programs through its...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $14,004.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,094,188 units of the HAVRIX 1,440 unit/mL syringe medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through December 31, 2025. The IDC allows the DLA to efficiently procure a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,800.70 firm fixed-price delivery order is for the supply of HAVRIX 1,440 unit/mL syringes. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,642.43 firm fixed-price delivery order is for the supply of 4,568,249,523 units of the HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract has an ultimate completion date of May 15, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,423.56 Firm Fixed Price Delivery Order is for the supply of 4,567,893,721 units of the HAVRIX 1,440 unit/mL syringe medication. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide HAVRIX 1,440 UNIT/ML SYRINGEML. The $1,833.70 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB23FL23T
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Havrix 1,440 unit/mL syringes. The award, worth $3,667.40, has a firm-fixed price and an ultimate completion date of March 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 12:38 PM